VBL Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Vascular Biogenics Ltd. - Ordinary Shares (VBLT)
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
vblrx.com
Company Research
Source: GlobeNewswire
Conference Call and Webcast at 8:30 a.m. EDT Today OVAL Phase 3 registration-enabling study investigating VB-111 in patients with platinum-resistant ovarian cancer remains on track in spite of COVID-19, with over 260 patients enrolled; next DSMC review expected 3Q21Closed public offering, raising gross proceeds of $28.3 millionAdditional $12.3 million raised during the first quarter, primarily through exercise of outstanding warrantsCash position expected to fund operations until year-end 2023, through OVAL study readout and potential BLA filingCompany to present update on OVAL at the ASCO conference TEL AVIV, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced financial results for the first quarter ended March 31, 2021 and provided a corporate update. “Our OVAL Phase 3 clinical trial remains on track and passed its most recent safety review, with the next one coming in the third quarter,” said Dror Harats, M.D., Chief Executive Officer of VB
Show less
Read more
Impact Snapshot
Event Time:
VBLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VBLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VBLT alerts
High impacting Vascular Biogenics Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics